Electric Therapy Traction Table Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
The global Hematologic Malignancies Detection market was valued at US$ 2299.4 million in 2022 and is projected to reach US$ 5743.9 million by 2029, at a CAGR of 14.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Increasing prevalence of hematological malignancies, emerging new technologies and methods for testing, patient preference for testing treatments, and increasing regulation across the healthcare industry are the key factors driving the growth of hematological malignancies testing market revenue.
Hematological malignancy is a major disease that seriously endangers human health. With the invention and application of polymerase chain reaction, immunohistochemistry, next-generation sequencing and fluorescence in situ hybridization, its overall diagnostic level has been significantly improved.
This report aims to provide a comprehensive presentation of the global market for Hematologic Malignancies Detection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hematologic Malignancies Detection. This report contains market size and forecasts of Hematologic Malignancies Detection in global, including the following market information:
Global Hematologic Malignancies Detection Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hematologic Malignancies Detection companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hematologic Malignancies Detection Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Hematologic Malignancies Detection Market Segment Percentages, by Type, 2022 (%)
Polymerase Chain Reaction
Immunochemistry
Next Generation Sequencing
Fluorescence in Situ Hybridization
Others
Global Hematologic Malignancies Detection Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Hematologic Malignancies Detection Market Segment Percentages, by Application, 2022 (%)
Multiple Myeloma
Myelodysplastic Syndrome
Leukemia
Myeloproliferative Neoplasms
Lymphoma
Others
Global Hematologic Malignancies Detection Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Hematologic Malignancies Detection Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hematologic Malignancies Detection revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Hematologic Malignancies Detection revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
ArcherDx
Bio-Rad Laboratories
sysmex
Invitae
NeoGenomics Laboratories
Abbott Laboratories
Cancer Genetics
Adaptive Biotechnologies Corporation
Asuragen
Invivoscribe
Nanjing Shihejiyin Technology
Annaroad Gene Technology
BGI Genomics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hematologic Malignancies Detection, market overview.
Chapter 2: Global Hematologic Malignancies Detection market size in revenue.
Chapter 3: Detailed analysis of Hematologic Malignancies Detection company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hematologic Malignancies Detection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Hematologic Malignancies Detection Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hematologic Malignancies Detection Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hematologic Malignancies Detection Overall Market Size
2.1 Global Hematologic Malignancies Detection Market Size: 2022 VS 2029
2.2 Global Hematologic Malignancies Detection Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hematologic Malignancies Detection Players in Global Market
3.2 Top Global Hematologic Malignancies Detection Companies Ranked by Revenue
3.3 Global Hematologic Malignancies Detection Revenue by Companies
3.4 Top 3 and Top 5 Hematologic Malignancies Detection Companies in Global Market, by Revenue in 2022
3.5 Global Companies Hematologic Malignancies Detection Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hematologic Malignancies Detection Players in Global Market
3.6.1 List of Global Tier 1 Hematologic Malignancies Detection Companies
3.6.2 List of Global Tier 2 and Tier 3 Hematologic Malignancies Detection Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Hematologic Malignancies Detection Market Size Markets, 2022 & 2029
4.1.2 Polymerase Chain Reaction
4.1.3 Immunochemistry
4.1.4 Next Generation Sequencing
4.1.5 Fluorescence in Situ Hybridization
4.1.6 Others
4.2 By Type - Global Hematologic Malignancies Detection Revenue & Forecasts
4.2.1 By Type - Global Hematologic Malignancies Detection Revenue, 2018-2023
4.2.2 By Type - Global Hematologic Malignancies Detection Revenue, 2024-2029
4.2.3 By Type - Global Hematologic Malignancies Detection Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hematologic Malignancies Detection Market Size, 2022 & 2029
5.1.2 Multiple Myeloma
5.1.3 Myelodysplastic Syndrome
5.1.4 Leukemia
5.1.5 Myeloproliferative Neoplasms
5.1.6 Lymphoma
5.1.7 Others
5.2 By Application - Global Hematologic Malignancies Detection Revenue & Forecasts
5.2.1 By Application - Global Hematologic Malignancies Detection Revenue, 2018-2023
5.2.2 By Application - Global Hematologic Malignancies Detection Revenue, 2024-2029
5.2.3 By Application - Global Hematologic Malignancies Detection Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Hematologic Malignancies Detection Market Size, 2022 & 2029
6.2 By Region - Global Hematologic Malignancies Detection Revenue & Forecasts
6.2.1 By Region - Global Hematologic Malignancies Detection Revenue, 2018-2023
6.2.2 By Region - Global Hematologic Malignancies Detection Revenue, 2024-2029
6.2.3 By Region - Global Hematologic Malignancies Detection Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Hematologic Malignancies Detection Revenue, 2018-2029
6.3.2 US Hematologic Malignancies Detection Market Size, 2018-2029
6.3.3 Canada Hematologic Malignancies Detection Market Size, 2018-2029
6.3.4 Mexico Hematologic Malignancies Detection Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Hematologic Malignancies Detection Revenue, 2018-2029
6.4.2 Germany Hematologic Malignancies Detection Market Size, 2018-2029
6.4.3 France Hematologic Malignancies Detection Market Size, 2018-2029
6.4.4 U.K. Hematologic Malignancies Detection Market Size, 2018-2029
6.4.5 Italy Hematologic Malignancies Detection Market Size, 2018-2029
6.4.6 Russia Hematologic Malignancies Detection Market Size, 2018-2029
6.4.7 Nordic Countries Hematologic Malignancies Detection Market Size, 2018-2029
6.4.8 Benelux Hematologic Malignancies Detection Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Hematologic Malignancies Detection Revenue, 2018-2029
6.5.2 China Hematologic Malignancies Detection Market Size, 2018-2029
6.5.3 Japan Hematologic Malignancies Detection Market Size, 2018-2029
6.5.4 South Korea Hematologic Malignancies Detection Market Size, 2018-2029
6.5.5 Southeast Asia Hematologic Malignancies Detection Market Size, 2018-2029
6.5.6 India Hematologic Malignancies Detection Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Hematologic Malignancies Detection Revenue, 2018-2029
6.6.2 Brazil Hematologic Malignancies Detection Market Size, 2018-2029
6.6.3 Argentina Hematologic Malignancies Detection Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hematologic Malignancies Detection Revenue, 2018-2029
6.7.2 Turkey Hematologic Malignancies Detection Market Size, 2018-2029
6.7.3 Israel Hematologic Malignancies Detection Market Size, 2018-2029
6.7.4 Saudi Arabia Hematologic Malignancies Detection Market Size, 2018-2029
6.7.5 UAE Hematologic Malignancies Detection Market Size, 2018-2029
7 Hematologic Malignancies Detection Companies Profiles
7.1 ArcherDx
7.1.1 ArcherDx Company Summary
7.1.2 ArcherDx Business Overview
7.1.3 ArcherDx Hematologic Malignancies Detection Major Product Offerings
7.1.4 ArcherDx Hematologic Malignancies Detection Revenue in Global Market (2018-2023)
7.1.5 ArcherDx Key News & Latest Developments
7.2 Bio-Rad Laboratories
7.2.1 Bio-Rad Laboratories Company Summary
7.2.2 Bio-Rad Laboratories Business Overview
7.2.3 Bio-Rad Laboratories Hematologic Malignancies Detection Major Product Offerings
7.2.4 Bio-Rad Laboratories Hematologic Malignancies Detection Revenue in Global Market (2018-2023)
7.2.5 Bio-Rad Laboratories Key News & Latest Developments
7.3 sysmex
7.3.1 sysmex Company Summary
7.3.2 sysmex Business Overview
7.3.3 sysmex Hematologic Malignancies Detection Major Product Offerings
7.3.4 sysmex Hematologic Malignancies Detection Revenue in Global Market (2018-2023)
7.3.5 sysmex Key News & Latest Developments
7.4 Invitae
7.4.1 Invitae Company Summary
7.4.2 Invitae Business Overview
7.4.3 Invitae Hematologic Malignancies Detection Major Product Offerings
7.4.4 Invitae Hematologic Malignancies Detection Revenue in Global Market (2018-2023)
7.4.5 Invitae Key News & Latest Developments
7.5 NeoGenomics Laboratories
7.5.1 NeoGenomics Laboratories Company Summary
7.5.2 NeoGenomics Laboratories Business Overview
7.5.3 NeoGenomics Laboratories Hematologic Malignancies Detection Major Product Offerings
7.5.4 NeoGenomics Laboratories Hematologic Malignancies Detection Revenue in Global Market (2018-2023)
7.5.5 NeoGenomics Laboratories Key News & Latest Developments
7.6 Abbott Laboratories
7.6.1 Abbott Laboratories Company Summary
7.6.2 Abbott Laboratories Business Overview
7.6.3 Abbott Laboratories Hematologic Malignancies Detection Major Product Offerings
7.6.4 Abbott Laboratories Hematologic Malignancies Detection Revenue in Global Market (2018-2023)
7.6.5 Abbott Laboratories Key News & Latest Developments
7.7 Cancer Genetics
7.7.1 Cancer Genetics Company Summary
7.7.2 Cancer Genetics Business Overview
7.7.3 Cancer Genetics Hematologic Malignancies Detection Major Product Offerings
7.7.4 Cancer Genetics Hematologic Malignancies Detection Revenue in Global Market (2018-2023)
7.7.5 Cancer Genetics Key News & Latest Developments
7.8 Adaptive Biotechnologies Corporation
7.8.1 Adaptive Biotechnologies Corporation Company Summary
7.8.2 Adaptive Biotechnologies Corporation Business Overview
7.8.3 Adaptive Biotechnologies Corporation Hematologic Malignancies Detection Major Product Offerings
7.8.4 Adaptive Biotechnologies Corporation Hematologic Malignancies Detection Revenue in Global Market (2018-2023)
7.8.5 Adaptive Biotechnologies Corporation Key News & Latest Developments
7.9 Asuragen
7.9.1 Asuragen Company Summary
7.9.2 Asuragen Business Overview
7.9.3 Asuragen Hematologic Malignancies Detection Major Product Offerings
7.9.4 Asuragen Hematologic Malignancies Detection Revenue in Global Market (2018-2023)
7.9.5 Asuragen Key News & Latest Developments
7.10 Invivoscribe
7.10.1 Invivoscribe Company Summary
7.10.2 Invivoscribe Business Overview
7.10.3 Invivoscribe Hematologic Malignancies Detection Major Product Offerings
7.10.4 Invivoscribe Hematologic Malignancies Detection Revenue in Global Market (2018-2023)
7.10.5 Invivoscribe Key News & Latest Developments
7.11 Nanjing Shihejiyin Technology
7.11.1 Nanjing Shihejiyin Technology Company Summary
7.11.2 Nanjing Shihejiyin Technology Business Overview
7.11.3 Nanjing Shihejiyin Technology Hematologic Malignancies Detection Major Product Offerings
7.11.4 Nanjing Shihejiyin Technology Hematologic Malignancies Detection Revenue in Global Market (2018-2023)
7.11.5 Nanjing Shihejiyin Technology Key News & Latest Developments
7.12 Annaroad Gene Technology
7.12.1 Annaroad Gene Technology Company Summary
7.12.2 Annaroad Gene Technology Business Overview
7.12.3 Annaroad Gene Technology Hematologic Malignancies Detection Major Product Offerings
7.12.4 Annaroad Gene Technology Hematologic Malignancies Detection Revenue in Global Market (2018-2023)
7.12.5 Annaroad Gene Technology Key News & Latest Developments
7.13 BGI Genomics
7.13.1 BGI Genomics Company Summary
7.13.2 BGI Genomics Business Overview
7.13.3 BGI Genomics Hematologic Malignancies Detection Major Product Offerings
7.13.4 BGI Genomics Hematologic Malignancies Detection Revenue in Global Market (2018-2023)
7.13.5 BGI Genomics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LED Light-Up Blanket Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 116 |
Pelvic Floor Functional Magnetic Stimulator Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Multi-Modality Biofeedback System Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
High Frequency Evaluation and Therapy Device Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Choose License Type
Why Choose Us ?
24/7 Research support
Quality assurance
Information security
The report efficiently evaluates the market from various dimensions to deliver an
end-product that is informative, elaborate, and accurate and includes detailed
market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast.
The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of
xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the
industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market
opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE
analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing
initiatives, pricing analysis, competitive landscape which help businesses in
decision making. The analysis data is based on current and historical market trends
which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any
organization to gain insight into specific business sector, aligned with specific area
of interest. Thus, SMI offers more accurate, pragmatic, and actionable information
specifically tailored to suit your business needs.
